Published on in Vol 9, No 10 (2020): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23543, first published .
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

Mohammed Albalawi   1 * , MD ;   Syed Ziauddin Ahmed Zaidi   2 * , MD ;   Nawal AlShehry   2 , MD ;   Ahmed AlAskar   3 , MD ;   Abdul Rehman Zia Zaidi   4 , MD ;   Rania Nagib Mohammed Abdallah   5 , MD ;   Abdul Salam   6 , DPhil ;   Ahmed AlSagheir   7 , MD ;   Nour AlMozain   8 , MD ;   Ghada Elgohary   9 , MD ;   Khalid Batarfi   10 , MD ;   Alia Alfaraedi   11 , MD ;   Osamah Khojah   11 , MD ;   Rehab Al-Ansari   12 , MD ;   Mona Alfaraj   13 , MD ;   Afra Dayel   14 , MD ;   Ahmed Al Bahrani   15 , MD ;   Arwa Nabhan Abdelhameed   16 , MD ;   Hind Alhumaidan   17 , MD ;   Jawaher M Al-Otaibi   18 , MD ;   Ghazala Radwi   19 , MD ;   Abdulrahman Raizah   3 , MD ;   Hind Shatry   3 , BSc ;   Sara Alsaleh   7 , MD ;   Hazzaa AlZahrani   20 , MD ;   Hani Al-Hashmi   21 * , MD

1 Department of Internal Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia

2 Department of Adult Hematology/Blood & Marrow Transplant, King Fahad Medical City, Riyadh, Saudi Arabia

3 King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia

4 Department of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia

5 Department of Pulmonary and Critical Care Medicine, King Fahad Medical City, Riyadh, Saudi Arabia

6 Department of Epidemiology and Biostatistics, King Fahad Specialist Hospital, Dammam, Saudi Arabia

7 Department of Hematology and Oncology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia

8 Department of Blood Bank, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

9 Oncology Center, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

10 Transfusion Medicine Services, Department of Pathology & Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia

11 King Saud University, Riyadh, Saudi Arabia

12 Department of Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia

13 Hematology Laboratory Section of Medical Laboratory Department, Qatif Central Hospital, Qatif, Saudi Arabia

14 Department of Hematopathology, King Fahad Specialist Hospital Dammam, Dammam, Saudi Arabia

15 Department of Transfusion Medicine and Stem Cell Processing, King Fahad Specialist Hospital, Dammam, Saudi Arabia

16 Department of Internal Medicine, Imam Abdulrahman Bin Faisal University, Al-Khobar, Saudi Arabia

17 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

18 Department of Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

19 Department of Hematology, University of Alberta, Edmonton, ON, Canada

20 Department of Hematology and Bone Marrow Transplantation Section, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

21 Adult Hematology & Stem Cell Transplantation Department, Oncology Centre, King Fahad Specialist Hospital, Dammam, Saudi Arabia

*these authors contributed equally

Corresponding Author:

  • Hani Al-Hashmi, MD
  • Adult Hematology & Stem Cell Transplantation Department
  • Oncology Centre
  • King Fahad Specialist Hospital
  • Amr Bin Thabet
  • P.O. Box 15373
  • Dammam, 31444
  • Saudi Arabia
  • Phone: 966 564773377
  • Email: hashmih@yahoo.com